Close Menu

single molecule array

Leveraging Quanterix's Simoa technology, PBL will be able to enter new markets and strengthen its current product offerings. 

The genome editing nucleases slide and hop along double-stranded DNA to find and bind to their target sequence.

Myriad RBM has manufactured and validated immunoassays based on Quanterix's single molecule array technology, Simoa.

The company's molecular detection technology relies on DNA supercoiling and binding target molecules to single-molecule biosensors within a capillary system.

NEW YORK (GenomeWeb) — Twistnostics this month was awarded $212,371 from the National Cancer Institute to support the second year of its project to develop an assay for detecting cancer mutations in circulating DNA in body fluids such as blood and urine.

A research team at the University of Gothenburg in Sweden is using Quanterix's Single Molecule Array, or Simoa, platform to identify blood biomarkers related to brain injury.

Quanterix this week launched a commercial, research-use-only version of its Single Molecule Array, Simoa, platform.

With its recent investment in Quanterix, French diagnostics firm BioMérieux has added that company's Single Molecule Array high-sensitivity immunoassay platform to its offerings and positioned itself to take advantage of not only its own internal research on the platform but outs

NEW YORK (GenomeWeb News) – BioMérieux and Quanterix announced today a deal granting BioMérieux worldwide exclusive rights to Quanterix's Single Molecule Array (SiMoA) technology in clinical laboratories and for industrial applications.

Researchers from Quanterix have published a study in the Journal of Virological Methods demonstrating use of the company's Simoa single-molecule immunoassay system for detect

Pages

The nonprofit Biden Cancer Initiative is suspending its operations, according to the Associated Press.

Researchers examine how white nationalists handle personal genetic ancestry results that conflict with their racist worldview, the New York Times reports.

NPR speaks with research participants before and after they learn their APOE E4 status, which affects their risk of developing Alzheimer's disease.

In PLOS this week: genetic characterization of Toxoplasma gondii strains, Crimean-Congo Hemorrhagic Fever Virus uncovered in Sudan, and more.